The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosome aberrations by 1,2:3,4-diepoxybutane

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 465, Issue 1-2, 2000, Pages 69-75

  Schlade Bartusiak, Kamilla ^a   Sasiadek, Maria ^a   Kozlowska, Joanna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Chromosome aberrations; Diepoxybutane; GSTM1; GSTT1; SCE

Indexed keywords

BUTADIENE DIEPOXIDE; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG SENSITIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; MALE; MICRONUCLEUS TEST; NORMAL HUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ADULT; CHROMOSOME ABERRATIONS; DRUG RESISTANCE; EPOXY COMPOUNDS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOCYTES; MALE; MUTAGENS; POLYMORPHISM, GENETIC; SISTER CHROMATID EXCHANGE;

EID: 0034673195     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00213-2     Document Type: Article

References (34)

1. H. Norppa, Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes, Environ. Health Perspect. 105 (Suppl. 4) (1997) 829-835.
2. I.-D. Adler, J. Cochrane, S. Osterman-Golkar, T.R. Skopek, M. Sorsa, E. Vogel, 1,3-Butadiene working group report, Mutat. Res. 330 (1995) 101-114.
3. S. Bernardini, K. Pelin, K. Peltonen, H. Jarventaus, A. Hirvonen, C. Neagu, M. Sorsa, H. Norppa, Induction of sister chromatid exchange by 3,4-epoxybutane-l,2-diol in cultured human lymphocytes of different GSTT1 and GSTM1 genotypes, Mutat. Res. 361 (1996) 121-127.
4. H.M. Bolt, M. Capellmann, B. Jelitto, U. Hindermeier, L.I. Kirkovsky, Differential reactivities of the mono- and diepoxide of 1,3-butadiene, Toxicology 113 (1996) 294-296.
5. M. Sasiadek, H. Norppa, M. Sorsa, 1,3-Butadiene and its epoxides induce sister-chromatid exchanges in human lymphocytes in vitro, Mutat. Res. 261 (1991) 117-121.
6. J.K. Wiencke, D.C. Christiani, K.T. Kelsey, Bimodal distribution to SCE induction by diepoxybutane in human lymphocytes: I. Correlation with chromosome aberrations, Mutat. Res. 248 (1991) 17-26.
7. M. Sasiadek, K. Schlade, H. Busza, H. Czemarmazowicz, A. Stembalska, Classical and molecular cytogenetics in analysis of diepoxybutane-induced chromosome aberrations, Mutat. Res. 419 (1998) 155-161.
8. L. Xi, L. Zhang, Y. Wang, M.T. Smith, Induction of chromosome-specific aneuploidy and micronuclei in human lymphocytes by metabolites of 1,3-butadiene, Carcinogenesis 18 (9) (1997) 1687-1693.
9. D. Vlachodimitropoulos, H. Norppa, K. Autio, J. Catalan, A. Hirvonen, G. Tasa, M. Uuskula, N.A. Demopoulos, M. Sorsa, GSTT1-dependent induction of centromere-negative and -positive micronuclei by l,2:3,4-diepoxybutane in cultured human lymphocytes, Mutagenesis 12 (1997) 397-403.
10. B. Ketterer, Effects of genetic polymorphism and enzyme induction in the glutathione S-transferase family on chemical safety and risk assessment, Environ. Toxicol. Pharmacol. 2 (1996) 157-160.
11. P. Vineis, Molecular epidemiology: low dose carcinogens and genetic susceptibility, Int. J. Cancer 71 (1997) 1-3.
12. F.J. Gonzalez, The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility, Reprod. Toxicol. 11 (2-3) (1997) 397-412.
13. F.P. Guengerich, R. Thier, M. Persmark, J.B. Taylor, S.E. Pemble, B. Ketterer, Conjugation of carcinogens by 9 class glutathione S-transferases: mechanism and relevance to variations in human risk, Pharmacogenetics 5 (1995) 103-107.
14. R.F. Henderson, J.R. Thornton-Manning, W.E. Bechtold, A.R. Dahl, Metabolism of 1,3-butadiene: species differences, Toxicology 113 (1996) 17-22.
15. A.A. Elfarra, R.J. Kryause, R.R. Selzer, Biochemistry of 1,3-butadiene metabolism and its relevance to 1,3-butadiene-induced carcinogenicity, Toxicology 113 (1996) 23-30.
16. D.A. Bell, J.A. Taylor, D.F. Paulson, C.N. Robertson, J.L. Mohler, G.W. Lucier, Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer, J. Natl. Cancer Inst. 85 (1993) 1159-1164.
17. H.H. Nelson, J.K. Wiencke, D.C. Christiani, T.J. Cheng, Z.-F. Zuo, B.S. Schwartz, B.-K. Lee, M.R. Spitz, M. Wang, X. Xu, K.T. Kelsey, Ethnic differences in the prevalence of the homozygous deleted genotype of glutathone S-transferase theta, Carcinogenesis 16 (1995) 1243-1245.
18. S. Pemble, K.R. Schroeder, S.R. Spencer, D.J. Meyer, E. Hallier, H.M. Bolt, B. Ketterer, J.B. Taylor, Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism, Biochem. J. 300 (1994) 271-276.
19. H. Chen, D.P. Sandier, J.A. Taylor, D.L. Shore, E. Liu, C.D. Bloomfield, D.A. Bell, Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect, Lancet 347 (1996) 295-297.
20. A. Hirvonen, K. Husgafvel-Pursiainen, S. Anttila, H. Vainio, The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung, Carcinogenesis 14 (1993) 1479-1481.
21. M. Kempkes, K. Golka, S. Reich, T. Reckwitz, Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder, Arch. Toxicol. 71 (1996) 123-126.
22. S. Zhong, A.H. Wyllie, D. Barnes, C.R. Wolf, N.K. Spurr, Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer, Carcinogenesis 14 (9) (1993) 1821-1824.
23. M. Sasiadek, A. Hirvonen, L. Noga, M. Paprocka-Borowicz, H. Norppa, Glutathione S-transferase Ml genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with l,2-epoxy-3butene, Mutat. Res. 439 (1999) 207-212.
24. S. Bernardini, A. Hirvonen, K. Pelin, H. Norppa, Induction of sister chromatid exchange by l,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype, Carcinogenesis 19 (1998) 377-380.
25. H. Norppa, A. Hirvonen, H. Jarventaus, M. Uuskula, G. Tasa, A. Ojajarvi, M. Sorsa, Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes, Carcinogenesis 16 (1995) 1261-1264.
26. S. Landi, I. Ponzanelli, A. Hirvonen, H. Norppa, R. Barale, Repeated analysis of sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes: effects of glutathione S-transferase T1 and M1 genotype, Mutat. Res. 351 (1996) 79-85.
27. S. Landi, H. Norppa, G. Frenzilli, G. Cipollini, I. Ponzanelli, R. Barale, A. Hirvonen, Individual sensitivity to cytogenetic effects of l,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes, Pharmacogenetics 8 (1998) 461-471.
28. S. Landi, I. Ponzanelli, G. Cipollini, G. Frenzilli, A. Luccini, C.P. Milillo, I. Sbrana, R. Barale, Modulating factors of individual sensitivity to diepoxybutane: chromosome aberrations induced in vitro in human lymphocytes, Mutagenesis 12 (1997) 17-22.
29. K.J. Husgafvel-Pursiainen, Maki-Paakkanen, H. Norppa, M. Sorsa, Smoking and sister chromatid exchange, Hereditas 92 (1980) 247-250.
30. United Kingdom Environmental Mutagen Society (UKEMS), Report of the UKEMS sub-committee on guidelines for mutagenicity testing, UKEMS, 1984, 43-56.
31. E.J. Tawn, D. Holdsworth, Mutagen-induced chromosome damage in human lymphocytes, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics. A Practical Approach, vol. II: Malignancy and acquired abnormalities, IRL Press, 1992, 189-208.
32. P.A. Benn, M.A. Perle, Chromosome staining and banding techniques, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics. A Practical Approach, IRL Press, 1986, 57-84.
33. J.K. Wiencke, D.C. Christiani, K.T. Kelsey, Gene deletion of Glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis, Cancer Epid. Biom. Prev. 4 (1995) 254-259.
34. S. Landi, H. Norppa, G. Frenzilli, G. Cipollini, I. Ponzanelli, R. Barale, A. Hirvonen, Individual sensitivity to cytogenetic effects l,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1, T1 genotypes, Pharmacogenetics 6 (1998) 461-471.